Companies: 10,795·Total market cap: $144.5T

BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp.

BCTXNASDAQHealthcare● Active

$3.09

+$0.01(+0.32%)

Market Cap$5820760

P/E Ratio—

52W High$36

52W Low$2.98

Avg Volume224K

Open$3.14

Beta1.64

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

BriaCell Therapeutics Corp.（BCTX）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · BCTX · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-14.48Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding1.9MShares outstanding history

Next EarningsTBAEarnings history

探索 BriaCell Therapeutics Corp. 数据

分析师预测$— · Buy

股息不分红

盈利EPS $-62.60-45.55%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$36.5M▼ 661.35% YoY

202320242025

FY 2025EPS$-62.60▼ 45.55% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$38.4MEPS: $-14.48View income statement →

分析师评级与目标价

Buy1 位分析师

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$3.09Current

$—Avg Target

$—High

合计: 1 · 买入占比: 100.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

BriaCell Therapeutics Corp.

$3.09+0.32%$5.8M #2

Allarity Therapeutics, Inc.

$1.58-1.86%$25.1M #3

Aspire Biopharma Holdings, Inc.

$6.65+24.53%$767,224 #4

$0.47-0.68%$6.2M #5

Citius Pharmaceuticals, Inc.

$0.59+5.21%$6.6M #6

Entero Therapeutics, Inc.

$2.85-5.00%$13.6M

股票表现

1D+0.32%

1W-5.79%

1M-26.25%

3M-19.95%

YTD-56.54%

1Y-91.12%

5Y-99.60%

关于 BriaCell Therapeutics Corp.

CEOWilliam V. Williams

IPO DateMar 14, 2012

Employees16

CountryCA

Websitebriacell.com

BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company primarily focused on developing innovative immunotherapies to combat cancer. The firm's leading experimental drug, Bria-IMT, is …

Biotechnology HealthcareNASDAQCA

关于股票概览与关键数据

BriaCell Therapeutics Corp.（BCTX）是 Biotechnology 行业的 Healthcare 类公司，于 Mar 14, 2012 在 NASDAQ 上市。截至最近交易日，BCTX 股价为 $3.09，市值约为 $5.8M。过去12个月累计回报 -91.12%，年初至今回报 -56.54%。

根据 1 位华尔街分析师，BriaCell Therapeutics Corp. 股票共识评级为Buy，12个月平均目标价为 $—。2025 财年 BriaCell Therapeutics Corp. 营收 —，净利润 -$36.5M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，BriaCell Therapeutics Corp.（BCTX）股价为 $3.09，在 NASDAQ 上市，52周区间为 $2.98 – $36.00。

BCTX 最新股价BCTX quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议